|
1
|
DeSantis CE, Ma J, Goding Sauer A, Newman
LA and Jemal A: Breast cancer statistics, 2017, racial disparity in
mortality by state. CA Cancer J Clin. 67:439–448. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang CY, Bai XY and Wang CH: Traditional
Chinese medicine: A treasured natural resource of anticancer drug
research and development. Am J Chin Med. 42:543–559. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cragg GM and Newman DJ: Natural products:
A continuing source of novel drug leads. Biochim Biophys Acta.
1830:3670–3695. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ding Q, Yang LX, Yang HW, Jiang C, Wang YF
and Wang S: Cytotoxic and antibacterial triterpenoids derivatives
from Clematis ganpiniana. J Ethnopharmacol. 126:382–385. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng L, Xia TS, Wang YF, Zhou W, Liang
XQ, Xue JQ, Shi L, Wang Y and Ding Q: The apoptotic effect of D
Rhamnose β-hederin, a novel oleanane-type triterpenoid saponin on
breast cancer cells. PLoS One. 9:e908482014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chin AR and Wang SE: Cancer-derived
extracellular vesicles: The ‘soil conditioner’ in breast cancer
metastasis? Cancer Metastasis Rev. 35:669–676. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Valadi H, Ekström K, Bossiös A, Sjostrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu X, Odenthal M and Fries JW: Exosomes as
miRNA carriers: Formation-function-future. Int J Mol Sci. 17(pii):
E20282016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu DD, Wu Y, Shen HY, Lv MM, Chen WX,
Zhang XH, Zhong SL, Tang JH and Zhao JH: Exosomes in development,
metastasis and drug resistance of breast cancer. Cancer Sci.
106:959–964. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen X, Liang H, Zhang J, Zen K and Zhang
CY: Secreted microRNAs: A new form of intercellular communication.
Trends Cell Biol. 22:125–132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhong S, Li W, Chen Z, Xu J and Zhao J:
MiR-222 and miR-29a contribute to the drug-resistance of breast
cancer cells. Gene. 531:8–14. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen WX, Liu XM, Lv MM, Chen L, Zhao JH,
Zhong SL, Ji MH, Hu Q, Luo Z, Wu JZ and Tang JH: Exosomes from
drug-resistant breast cancer cells transmit chemoresistance by a
horizontal transfer of microRNAs. PLoS One. 9:e952402014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen WX, Cai YQ, Lv MM, Chen L, Zhong SL,
Ma TF, Zhao JH and Tang JH: Exosomes from docetaxel-resistant
breast cancer cells alter chemosensitivity by delivering microRNAs.
Tumour Biol. 35:9649–9659. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miot S, Gianni-Barrera R, Pelttari K,
Acharya C, Mainil-Varlet P, Juelke H, Jaquiery C, Candrian C,
Barbero A and Martin I: In vitro and in vivo validation of human
and goat chondrocyte labeling by green fluorescent protein
lentivirus transduction. Tissue Eng Part C Methods. 16:11–21. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Corcoran C, Rani S, O'Brien K, O'Neill A,
Prencipe M, Sheikh R, Webb G, McDermott R, Watson W, Crown J and
O'Driscoll L: Docetaxel-resistance in prostate cancer: Evaluating
associated phenotypic changes and potential for resistance transfer
via exosomes. PLoS One. 7:e509992012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jaiswal R, Luk F, Gong J, Mathys JM, Grau
GE and Bebawy M: Microparticle conferred microRNA
profiles-implications in the transfer and dominance of cancer
traits. Mol Cancer. 11:372012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X: Computational prediction of
microRNA targets. Methods Mol Biol. 667:283–295. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kanehisa M, Araki M, Goto S, Hattori M,
Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T
and Yamanishi Y: KEGG for linking genomes to life and the
environment. Nucleic Acids Res. 36(Database issue): D480–D484.
2008.PubMed/NCBI
|
|
20
|
Huang DW, Sherman BT, Tan Q, Kir J, Liu D,
Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC and Lempicki RA:
DAVID bioinformatics resources: Expanded annotation database and
novel algorithms to better extract biology from large gene lists.
Nucleic Acids Res. 35(Web Server Issue): W169–W175. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen WX, Zhong SL, Ji MH, Pan M, Hu Q, Lv
MM, Luo Z, Zhao JH and Tang JH: MicroRNAs delivered by
extracellular vesicles: An emerging resistance mechanism for breast
cancer. Tumour Biol. 35:2883–2892. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Palma J, Yaddanapudi SC, Pigati L, Havens
MA, Jeong S, Weiner GA, Weimer KM, Stern B, Hastings ML and Duelli
DM: MicroRNAs are exported from malignant cells in customized
particles. Nucleic Acids Res. 40:9125–9138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gibbings DJ, Ciaudo C, Erhardt M and
Voinnet O: Multivesicular bodies associate with components of miRNA
effector complexes and modulate miRNA activity. Nat Cell Biol.
11:1143–1149. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dey N, De P and Leyland-Jones B:
PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell
signaling to clinical trials. Pharmacol Ther. 175:91–106. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou BP and Hung MC: Dysregulation of
cellular signaling by HER2/neu in breast cancer. Semin Oncol.
30:38–48. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang J, Shao N, Ding X, Tan B, Song Q,
Wang N, Jia Y, Ling H and Cheng Y: Crosstalk between transforming
growth factor-beta signaling pathway and long non-coding RNAs in
cancer. Cancer Lett. 370:296–301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miyamoto Y, Suyama K and Baba H: Recent
advances in targeting the EGFR signaling pathway for the treatment
of metastatic colorectal cancer. Int J Mol Sci. 18(pii): E7522017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kosaka N, Iguchi H, Hagiwara K, Yoshioka
Y, Takeshita F and Ochiya T: Neutral sphingomyelinase 2
(nSMase2)-dependent exosomal transfer of angiogenic microRNAs
regulate cancer cell metastasis. J Biol Chem. 288:10849–10859.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morel L, Regan M, Higashimori H, Ng SK,
Esau C, Vidensky S, Rothstein J and Yang Y: Neuronal exosomal
miRNA-dependent translational regulation of astroglial glutamate
transporter GLT1. J Biol Chem. 288:7105–7116. 2013. View Article : Google Scholar : PubMed/NCBI
|
